Elena Del Alcázar-Viladomiu

10PUBLICATIONS
46CO-AUTHORS
PharmacogenomicsCardiology (incl. cardiovascular diseases)Tumour immunologyNanomedicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 19, 2025
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry.

María Olivares-Guerrero, Esteban Daudén, Josep Riera-Monroig

|Apr 30, 2025
Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry.

Juan José Lluch-Galcerá, José Manuel Carrascosa, Alicia González-Quesada

|Jun 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Andrea Chiricozzi, Giulia Coscarella, Luis Puig

|Aug 25, 2023
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.

Sonsoles Berenguer-Ruiz, Mario Aparicio-Domínguez, Pedro Herranz-Pinto

|Aug 10, 2023
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients.

Nerea Manzanares, Eva Vilarrasa, Anna López

|Sep 29, 2022
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group.

Vicenç Rocamora, Laura Crespi, Marta Ferran

Pageof 2

Frequent Collaborators

7 joint publications

Mar Llamas-Velasco

7 joint publications

José-Manuel Carrascosa

5 joint publications

Raquel Rivera-Diaz

4 joint publications

Antonio Sahuquillo-Torralba